Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2025-12-24 @ 10:52 PM
NCT ID:
NCT03339869
Eligibility Criteria:
Inclusion Criteria:
* Adult patient (age\> 18 years)
* Patient hospitalized in intensive care for a duration greater than 7 days, treated with cefotaxime, ceftazidime, cefepime, piperacillin or meropenem according to a standardized dosing regimen.
Exclusion Criteria:
* Age \<18
* Pregnant woman
* Patient allergic to beta-lactams
* No written informed consent by the patient or his/her (legal) representative
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03339869
Study Brief:
Protocol Section:
NCT03339869